Nexavar is the sort of competition that biotech investors have nightmares about. The market can't ignore this threat for much longer, and a share price of $2 isn't out of the question.
Nexavar is the sort of competition that biotech investors have...
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $71.64M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 43.5¢ | 43.5¢ | $69.31K | 159.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 788030 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 95406 | 2 |
View Market Depth
| Last trade - 15.48pm 28/06/2024 (20 minute delay) ? |
| PGL (ASX) Chart |